Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed

被引：0

作者：

Ketter, T. A. ^{[1
]}

Citrome, L. ^{[2
]}

Cucchiaro, J. ^{[3
]}

Loebel, A. ^{[3
]}

机构：

[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA

[2] New York Med Coll, Pomona, NJ USA

[3] Sunov Pharmaceut Inc, Ft Lee, NJ USA

来源：

BIPOLAR DISORDERS | 2013年 / 15卷

关键词：

bipolar disorder; depressed; atypical antipsychotics; lurasidone;

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：92 / 92

页数：1

共 50 条

[1] Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed
Citrome, L.
Ketter, T.
Cucchiaro, J.
Loebel, A.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 54 - 54
[2] Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed
Citrome, Leslie
Ketter, Terence A.
Cucchiaro, Josephine
Loebel, Antony
JOURNAL OF AFFECTIVE DISORDERS, 2014, 155 : 20 - 27
[3] Clinical Assessment of Lurasidone Benefit and Risk in the Treatment of Bipolar I Depression Using Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
Citrome, Leslie
Ketter, Terence A.
Cucchiaro, Josephine
Loebel, Antony
NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S359 - S361
[4] Cariprazine for bipolar depression: What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome, Leslie
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2019, 73 (10)
[5] Quantitative Benefit-Risk Assessment of Rosiglitazone: Number Needed to Treat, Number Needed to Harm and Likelihood to be Helped or Harmed
Mendes, D.
Alves, C.
Batel-Marques, F.
DRUG SAFETY, 2014, 37 (10) : 859 - 859
[6] Lumateperone for the Treatment of Schizophrenia: Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed br br
Citrome, Leslie
Durgam, Suresh
Edwards, John B.
Davis, Robert E.
JOURNAL OF CLINICAL PSYCHIATRY, 2023, 84 (02)
[7] Lemborexant and Daridorexant for the Treatment of Insomnia: An Indirect Comparison, Using Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed
Citrome, Leslie
Juday, Timothy
Lundwall, Christie
CNS SPECTRUMS, 2023, 28 (02) : 265 - 265
[8] DARIDOREXANT IN PATIENTS WITH INSOMNIA DISORDER: NUMBER NEEDED TO TREAT, NUMBER NEEDED TO HARM & LIKELIHOOD TO BE HELPED OR HARMED
Chalet, Francois-Xavier
Luyet, Pierre-Philippe
Rabasa, Cristina
Vaillant, Cedric
Saskin, Paul
Ahuja, Ajay
Citrome, Leslie
SLEEP, 2023, 46 : A155 - A155
[9] Lemborexant and Daridorexant for the Treatment of Insomnia: An Indirect Comparison Using Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed
Citrome, Leslie
Juday, Timothy R.
Lundwall, Christie
JOURNAL OF CLINICAL PSYCHIATRY, 2023, 84 (06) : E1 - E11
[10] Pimavanserin for the treatment of Parkinson's disease psychosis: number needed to treat, number needed to harm, and likelihood to be helped or harmed
Citrome, Leslie
Norton, James C.
Chi-Burris, Kathy
Demos, George
CNS SPECTRUMS, 2018, 23 (03) : 228 - 238

← 1 2 3 4 5 →